IBDEI0E7 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19189,1,4,0)
 ;;=4^V10.42
 ;;^UTILITY(U,$J,358.3,19189,1,5,0)
 ;;=5^HX-UTERUS MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19189,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,19190,0)
 ;;=V10.43^^120^1155^19
 ;;^UTILITY(U,$J,358.3,19190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19190,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,19190,1,5,0)
 ;;=5^HX OF OVARIAN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19190,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,19191,0)
 ;;=V10.44^^120^1155^26
 ;;^UTILITY(U,$J,358.3,19191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19191,1,4,0)
 ;;=4^V10.44
 ;;^UTILITY(U,$J,358.3,19191,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NEC
 ;;^UTILITY(U,$J,358.3,19191,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,19192,0)
 ;;=V10.45^^120^1155^34
 ;;^UTILITY(U,$J,358.3,19192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19192,1,4,0)
 ;;=4^V10.45
 ;;^UTILITY(U,$J,358.3,19192,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NOS
 ;;^UTILITY(U,$J,358.3,19192,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,19193,0)
 ;;=V10.46^^120^1155^39
 ;;^UTILITY(U,$J,358.3,19193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19193,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,19193,1,5,0)
 ;;=5^HX-PROSTATIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19193,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,19194,0)
 ;;=V10.47^^120^1155^43
 ;;^UTILITY(U,$J,358.3,19194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19194,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,19194,1,5,0)
 ;;=5^HX-TESTICULAR MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19194,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,19195,0)
 ;;=V10.48^^120^1155^48
 ;;^UTILITY(U,$J,358.3,19195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19195,1,4,0)
 ;;=4^V10.48
 ;;^UTILITY(U,$J,358.3,19195,1,5,0)
 ;;=5^PSNL HX MAL NEOPL-EPIDID
 ;;^UTILITY(U,$J,358.3,19195,2)
 ;;=^321226
 ;;^UTILITY(U,$J,358.3,19196,0)
 ;;=V10.49^^120^1155^33
 ;;^UTILITY(U,$J,358.3,19196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19196,1,4,0)
 ;;=4^V10.49
 ;;^UTILITY(U,$J,358.3,19196,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NEC
 ;;^UTILITY(U,$J,358.3,19196,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,19197,0)
 ;;=V10.50^^120^1155^46
 ;;^UTILITY(U,$J,358.3,19197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19197,1,4,0)
 ;;=4^V10.50
 ;;^UTILITY(U,$J,358.3,19197,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,19197,2)
 ;;=^295227
 ;;^UTILITY(U,$J,358.3,19198,0)
 ;;=V10.51^^120^1155^1
 ;;^UTILITY(U,$J,358.3,19198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19198,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,19198,1,5,0)
 ;;=5^HX OF BLADDER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19198,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,19199,0)
 ;;=V10.52^^120^1155^10
 ;;^UTILITY(U,$J,358.3,19199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19199,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,19199,1,5,0)
 ;;=5^HX OF KIDNEY MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19199,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,19200,0)
 ;;=V10.53^^120^1155^15
 ;;^UTILITY(U,$J,358.3,19200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19200,1,4,0)
 ;;=4^V10.53
 ;;^UTILITY(U,$J,358.3,19200,1,5,0)
 ;;=5^HX OF MAL NEOPLASM,RENAL PELVIS
 ;;^UTILITY(U,$J,358.3,19200,2)
 ;;=^323624
 ;;^UTILITY(U,$J,358.3,19201,0)
 ;;=V10.59^^120^1155^45
 ;;^UTILITY(U,$J,358.3,19201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19201,1,4,0)
 ;;=4^V10.59
 ;;^UTILITY(U,$J,358.3,19201,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NEC
 ;;^UTILITY(U,$J,358.3,19201,2)
 ;;=^295230
 ;;^UTILITY(U,$J,358.3,19202,0)
 ;;=V10.60^^120^1155^12
 ;;^UTILITY(U,$J,358.3,19202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19202,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,19202,1,5,0)
 ;;=5^HX OF LEUKEMIA NOS
 ;;^UTILITY(U,$J,358.3,19202,2)
 ;;=^295231
 ;;^UTILITY(U,$J,358.3,19203,0)
 ;;=V10.61^^120^1155^14
 ;;^UTILITY(U,$J,358.3,19203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19203,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,19203,1,5,0)
 ;;=5^HX OF LYMPHOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19203,2)
 ;;=^295232
 ;;^UTILITY(U,$J,358.3,19204,0)
 ;;=V10.62^^120^1155^18
 ;;^UTILITY(U,$J,358.3,19204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19204,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,19204,1,5,0)
 ;;=5^HX OF MYELOID LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19204,2)
 ;;=^295233
 ;;^UTILITY(U,$J,358.3,19205,0)
 ;;=V10.63^^120^1155^17
 ;;^UTILITY(U,$J,358.3,19205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19205,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,19205,1,5,0)
 ;;=5^HX OF MONOCYTIC LEUKEMIA
 ;;^UTILITY(U,$J,358.3,19205,2)
 ;;=^295234
 ;;^UTILITY(U,$J,358.3,19206,0)
 ;;=V10.69^^120^1155^11
 ;;^UTILITY(U,$J,358.3,19206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19206,1,4,0)
 ;;=4^V10.69
 ;;^UTILITY(U,$J,358.3,19206,1,5,0)
 ;;=5^HX OF LEUKEMIA NEC
 ;;^UTILITY(U,$J,358.3,19206,2)
 ;;=^295235
 ;;^UTILITY(U,$J,358.3,19207,0)
 ;;=V10.71^^120^1155^32
 ;;^UTILITY(U,$J,358.3,19207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19207,1,4,0)
 ;;=4^V10.71
 ;;^UTILITY(U,$J,358.3,19207,1,5,0)
 ;;=5^HX-LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,19207,2)
 ;;=^295236
 ;;^UTILITY(U,$J,358.3,19208,0)
 ;;=V10.72^^120^1155^28
 ;;^UTILITY(U,$J,358.3,19208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19208,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,19208,1,5,0)
 ;;=5^HX-HODGKIN'S DISEASE
 ;;^UTILITY(U,$J,358.3,19208,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,19209,0)
 ;;=V10.79^^120^1155^31
 ;;^UTILITY(U,$J,358.3,19209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19209,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,19209,1,5,0)
 ;;=5^HX-LYMPHATIC MALIGN NEC
 ;;^UTILITY(U,$J,358.3,19209,2)
 ;;=^295238
 ;;^UTILITY(U,$J,358.3,19210,0)
 ;;=V10.81^^120^1155^2
 ;;^UTILITY(U,$J,358.3,19210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19210,1,4,0)
 ;;=4^V10.81
 ;;^UTILITY(U,$J,358.3,19210,1,5,0)
 ;;=5^HX OF BONE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19210,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,19211,0)
 ;;=V10.82^^120^1155^35
 ;;^UTILITY(U,$J,358.3,19211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19211,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,19211,1,5,0)
 ;;=5^HX-MALIG SKIN MELANOMA
 ;;^UTILITY(U,$J,358.3,19211,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,19212,0)
 ;;=V10.83^^120^1155^42
 ;;^UTILITY(U,$J,358.3,19212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19212,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,19212,1,5,0)
 ;;=5^HX-SKIN MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19212,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,19213,0)
 ;;=V10.84^^120^1155^6
 ;;^UTILITY(U,$J,358.3,19213,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19213,1,4,0)
 ;;=4^V10.84
 ;;^UTILITY(U,$J,358.3,19213,1,5,0)
 ;;=5^HX OF EYE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19213,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,19214,0)
 ;;=V10.85^^120^1155^3
 ;;^UTILITY(U,$J,358.3,19214,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19214,1,4,0)
 ;;=4^V10.85
 ;;^UTILITY(U,$J,358.3,19214,1,5,0)
 ;;=5^HX OF BRAIN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19214,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,19215,0)
 ;;=V10.86^^120^1155^36
 ;;^UTILITY(U,$J,358.3,19215,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19215,1,4,0)
 ;;=4^V10.86
 ;;^UTILITY(U,$J,358.3,19215,1,5,0)
 ;;=5^HX-MALIGN NERVE SYST NEC
 ;;^UTILITY(U,$J,358.3,19215,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,19216,0)
 ;;=V10.87^^120^1155^20
 ;;^UTILITY(U,$J,358.3,19216,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19216,1,4,0)
 ;;=4^V10.87
 ;;^UTILITY(U,$J,358.3,19216,1,5,0)
 ;;=5^HX OF THYROID MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19216,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,19217,0)
 ;;=V10.88^^120^1155^24
 ;;^UTILITY(U,$J,358.3,19217,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19217,1,4,0)
 ;;=4^V10.88
 ;;^UTILITY(U,$J,358.3,19217,1,5,0)
 ;;=5^HX-ENDOCRINE MALIGN NEC
 ;;^UTILITY(U,$J,358.3,19217,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,19218,0)
 ;;=V10.89^^120^1155^16
 ;;^UTILITY(U,$J,358.3,19218,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19218,1,4,0)
 ;;=4^V10.89
 ;;^UTILITY(U,$J,358.3,19218,1,5,0)
 ;;=5^HX OF MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19218,2)
 ;;=^295247
 ;;^UTILITY(U,$J,358.3,19219,0)
 ;;=V45.71^^120^1156^7
 ;;^UTILITY(U,$J,358.3,19219,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19219,1,4,0)
 ;;=4^V45.71
 ;;^UTILITY(U,$J,358.3,19219,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF BREAST
 ;;^UTILITY(U,$J,358.3,19219,2)
 ;;=^336882
 ;;^UTILITY(U,$J,358.3,19220,0)
 ;;=V45.72^^120^1156^6
 ;;^UTILITY(U,$J,358.3,19220,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19220,1,4,0)
 ;;=4^V45.72
 ;;^UTILITY(U,$J,358.3,19220,1,5,0)
 ;;=5^ACQ. ABS. OF INTESTINE (LG,SM)
 ;;^UTILITY(U,$J,358.3,19220,2)
 ;;=^317959
 ;;^UTILITY(U,$J,358.3,19221,0)
 ;;=V45.73^^120^1156^8
 ;;^UTILITY(U,$J,358.3,19221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19221,1,4,0)
 ;;=4^V45.73
 ;;^UTILITY(U,$J,358.3,19221,1,5,0)
 ;;=5^ACQUIRED ABSENCE OF KIDNEY
 ;;^UTILITY(U,$J,358.3,19221,2)
 ;;=^317962
 ;;^UTILITY(U,$J,358.3,19222,0)
 ;;=V45.74^^120^1156^4
 ;;^UTILITY(U,$J,358.3,19222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19222,1,4,0)
 ;;=4^V45.74
 ;;^UTILITY(U,$J,358.3,19222,1,5,0)
 ;;=5^ACQ ABSENCE ORG,URINARY TRACT
 ;;^UTILITY(U,$J,358.3,19222,2)
 ;;=^322063
 ;;^UTILITY(U,$J,358.3,19223,0)
 ;;=V45.75^^120^1156^3
 ;;^UTILITY(U,$J,358.3,19223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19223,1,4,0)
 ;;=4^V45.75
 ;;^UTILITY(U,$J,358.3,19223,1,5,0)
 ;;=5^ACQ ABSENCE ORG,STOMACH
 ;;^UTILITY(U,$J,358.3,19223,2)
 ;;=^322065
 ;;^UTILITY(U,$J,358.3,19224,0)
 ;;=V45.76^^120^1156^2
 ;;^UTILITY(U,$J,358.3,19224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19224,1,4,0)
 ;;=4^V45.76
 ;;^UTILITY(U,$J,358.3,19224,1,5,0)
 ;;=5^ACQ ABSENCE ORG,LUNG
 ;;^UTILITY(U,$J,358.3,19224,2)
 ;;=^322066
 ;;^UTILITY(U,$J,358.3,19225,0)
 ;;=V45.77^^120^1156^1
 ;;^UTILITY(U,$J,358.3,19225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19225,1,4,0)
 ;;=4^V45.77
 ;;^UTILITY(U,$J,358.3,19225,1,5,0)
 ;;=5^ACQ ABSENCE ORG,GENITALS
 ;;^UTILITY(U,$J,358.3,19225,2)
 ;;=^322067
